Wen Shuhao, Xtalpi's cofounder and chairman, speaks at the company's IPO ceremony in Hong Kong on June 13, 2024. Shanshan Kao/Forbes Asia ByZinnia Lee, Forbes Staff. I cover successful ...
Coverage of obesity drugs in health plans and the rapid adoption of artificial intelligence are two areas of change that health plans will face during the coming year. A panel of Avalere experts ...
AI for accelerated antibody discovery Traditionally ... where such platforms are affecting the status quo and transforming the way we discover drugs. Vertex's gene-editing therapy for sickle ...
Company’s Advanced Checkpoint Screening Technology Poised to Become an Essential Tool in the Detection and Seizure of Fentanyl and Other Contraband at the US-Canadian BorderAtlanta, GA, Feb. 03, 2025 ...
The launch of the first drugs to inhibit the cancer-related ... and these will be used along with artificial intelligence and big data-powered drug design to look for small molecules that can ...